| P50 | author | Nicholas John White | Q21166848 |
| P2093 | author name string | Paul N Newton | |
| | Wirongrong Chierakul | |
| | Karen I Barnes | |
| | Peter J Smith | |
| | Ronatrai Ruangveerayuth | |
| | Alicia C Evans | |
| P2860 | cites work | Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. | Q47987503 |
| | Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination | Q48009282 |
| | Assessment of the pharmacodynamic properties of antimalarial drugs in vivo | Q24670346 |
| | Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial | Q33222370 |
| | Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma | Q33425382 |
| | Unexpected observation of ion suppression in a liquid chromatography/atmospheric pressure chemical ionization mass spectrometric bioanalytical method | Q33431699 |
| | Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria | Q33979153 |
| | Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. | Q33981168 |
| | Oral artesunate dose-response relationship in acute falciparum malaria | Q34113505 |
| | A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. | Q35802096 |
| | Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. | Q36671618 |
| | Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria | Q37598749 |
| | Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria | Q38906771 |
| | Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria | Q38925755 |
| | Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations. | Q39301017 |
| | Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria | Q39301037 |
| | A simple method for assessing quinine pre-treatment in acute malaria | Q39462284 |
| | The treatment of malaria | Q39590029 |
| | Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives | Q39590054 |
| | Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria | Q40932349 |
| | Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate. | Q47828067 |
| P433 | issue | 12 | |
| P921 | main subject | malaria | Q12156 |
| | Plasmodium falciparum | Q311383 |
| | pharmacokinetics | Q323936 |
| | artesunate | Q707939 |
| P304 | page(s) | 1003-1009 | |
| P577 | publication date | 2006-11-07 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria | |
| P478 | volume | 62 | |